- ·The complete investor list: 22 names
- ·Watch SymphoRNA: the Monday email on marks, rounds and moves
SymphoRNA funding history
No funding rounds for SymphoRNA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
SymphoRNA valuation
SymphoRNA's last known valuation is $98.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How SymphoRNA's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For SymphoRNA, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about SymphoRNA
- What is SymphoRNA worth?
- SymphoRNA's last known valuation is $98.4M.
- How much has SymphoRNA raised?
- SymphoRNA has raised $49.2M in total funding across its recorded rounds.